Header Logo

Connection

LISA SULLIVAN to Middle Aged

Back to Details
This is a "connection" page, showing publications LISA SULLIVAN has written about Middle Aged.
LISA SULLIVAN
Connection Strength
0.449
Middle Aged
  1. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004 May 30; 23(10):1631-60.
    View in: PubMed
    Score: 0.014
  2. Association of Parental Obesity and Diabetes Mellitus With Circulating Adipokines in Nonobese Nondiabetic Offspring. J Am Heart Assoc. 2017 Jul 16; 6(7).
    View in: PubMed
    Score: 0.009
  3. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc. 2017 Jul 16; 6(7).
    View in: PubMed
    Score: 0.009
  4. Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. Circulation. 2017 Mar 21; 135(12):1145-1159.
    View in: PubMed
    Score: 0.009
  5. Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study. J Am Heart Assoc. 2016 07 06; 5(7).
    View in: PubMed
    Score: 0.008
  6. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study. Atherosclerosis. 2016 May; 248:245-51.
    View in: PubMed
    Score: 0.008
  7. Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort. Hypertension. 2016 Feb; 67(2):294-300.
    View in: PubMed
    Score: 0.008
  8. Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment. J Am Heart Assoc. 2015 Nov 20; 4(11).
    View in: PubMed
    Score: 0.008
  9. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016 Jan; 13(1):233-40.
    View in: PubMed
    Score: 0.008
  10. Association of soda consumption with subclinical cardiac remodeling in the Framingham heart study. Metabolism. 2015 Feb; 64(2):208-12.
    View in: PubMed
    Score: 0.007
  11. Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet. 2014 Dec; 7(6):864-72.
    View in: PubMed
    Score: 0.007
  12. Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. Metab Syndr Relat Disord. 2014 Sep; 12(7):372-80.
    View in: PubMed
    Score: 0.007
  13. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2014 Apr; 7(2):307-12.
    View in: PubMed
    Score: 0.007
  14. Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes. Eur Heart J. 2014 Nov 07; 35(42):2980-7.
    View in: PubMed
    Score: 0.007
  15. Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail. 2013 Aug; 15(8):843-9.
    View in: PubMed
    Score: 0.007
  16. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013 Jan 01; 127(1):33-8.
    View in: PubMed
    Score: 0.006
  17. Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012 Dec; 60(6):1393-9.
    View in: PubMed
    Score: 0.006
  18. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1943-7.
    View in: PubMed
    Score: 0.006
  19. Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study. Int J Androl. 2012 Dec; 35(6):775-782.
    View in: PubMed
    Score: 0.006
  20. Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J. 2012 Apr; 163(4):729-34.
    View in: PubMed
    Score: 0.006
  21. Circulating vascular growth factors and central hemodynamic load in the community. Hypertension. 2012 Apr; 59(4):773-9.
    View in: PubMed
    Score: 0.006
  22. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J. 2012 Jan; 163(1):119-124.e1.
    View in: PubMed
    Score: 0.006
  23. Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. J Nutr. 2011 Dec; 141(12):2186-90.
    View in: PubMed
    Score: 0.006
  24. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort. Clin Chem Lab Med. 2011 Nov; 49(11):1907-10.
    View in: PubMed
    Score: 0.006
  25. Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circ Res. 2011 Aug 19; 109(5):554-63.
    View in: PubMed
    Score: 0.006
  26. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia. 2011 May; 54(5):1019-24.
    View in: PubMed
    Score: 0.006
  27. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension. 2011 Mar; 57(3):390-6.
    View in: PubMed
    Score: 0.006
  28. P wave duration and risk of longitudinal atrial fibrillation in persons = 60 years old (from the Framingham Heart Study). Am J Cardiol. 2011 Mar 15; 107(6):917-921.e1.
    View in: PubMed
    Score: 0.006
  29. Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. Diabetes Res Clin Pract. 2011 Apr; 92(1):124-7.
    View in: PubMed
    Score: 0.006
  30. Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr. 2011 Feb; 93(2):261-6.
    View in: PubMed
    Score: 0.006
  31. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010 Nov 22; 170(21):1909-17.
    View in: PubMed
    Score: 0.006
  32. P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2010 Oct; 15(4):344-52.
    View in: PubMed
    Score: 0.006
  33. Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study. Circulation. 2010 Aug 31; 122(9):884-90.
    View in: PubMed
    Score: 0.005
  34. Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation. 2010 Aug 10; 122(6):570-8.
    View in: PubMed
    Score: 0.005
  35. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol. 2010 Jul; 30(7):1479-84.
    View in: PubMed
    Score: 0.005
  36. Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community. Circ Cardiovasc Genet. 2010 Jun; 3(3):300-6.
    View in: PubMed
    Score: 0.005
  37. Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community. Circulation. 2010 Feb 09; 121(5):667-74.
    View in: PubMed
    Score: 0.005
  38. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010 Jan 19; 121(2):200-7.
    View in: PubMed
    Score: 0.005
  39. P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):77-84.
    View in: PubMed
    Score: 0.005
  40. The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism. 2010 Apr; 59(4):540-6.
    View in: PubMed
    Score: 0.005
  41. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem. 2009 Aug; 55(8):1539-45.
    View in: PubMed
    Score: 0.005
  42. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation. 2009 Jun 23; 119(24):3085-92.
    View in: PubMed
    Score: 0.005
  43. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke. 2009 Aug; 40(8):2715-9.
    View in: PubMed
    Score: 0.005
  44. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation. 2009 Mar 31; 119(12):1592-600.
    View in: PubMed
    Score: 0.005
  45. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009 Feb 28; 373(9665):739-45.
    View in: PubMed
    Score: 0.005
  46. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J. 2009 May; 30(9):1121-7.
    View in: PubMed
    Score: 0.005
  47. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008 Nov 20; 359(21):2208-19.
    View in: PubMed
    Score: 0.005
  48. Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample. Atherosclerosis. 2009 May; 204(1):282-7.
    View in: PubMed
    Score: 0.005
  49. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab. 2008 Aug; 93(8):3165-72.
    View in: PubMed
    Score: 0.005
  50. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol. 2008 Feb 15; 101(4):497-501.
    View in: PubMed
    Score: 0.005
  51. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007 Aug 15; 298(7):776-85.
    View in: PubMed
    Score: 0.004
  52. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007 Jul 31; 116(5):480-8.
    View in: PubMed
    Score: 0.004
  53. Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med. 2007 Jul-Aug; 69(6):509-13.
    View in: PubMed
    Score: 0.004
  54. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation. 2007 Jul 24; 116(4):375-84.
    View in: PubMed
    Score: 0.004
  55. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007 May 28; 167(10):1068-74.
    View in: PubMed
    Score: 0.004
  56. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007 May 14; 167(9):879-85.
    View in: PubMed
    Score: 0.004
  57. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007 Jun; 56(6):1718-26.
    View in: PubMed
    Score: 0.004
  58. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007 May; 30(5):1219-25.
    View in: PubMed
    Score: 0.004
  59. Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension. 2007 Mar; 49(3):439-45.
    View in: PubMed
    Score: 0.004
  60. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006 Aug; 91(8):2906-12.
    View in: PubMed
    Score: 0.004
  61. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006 Feb; 55(2):530-7.
    View in: PubMed
    Score: 0.004
  62. Social networks and inflammatory markers in the Framingham Heart Study. J Biosoc Sci. 2006 Nov; 38(6):835-42.
    View in: PubMed
    Score: 0.004
  63. Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2006 Apr 01; 163(7):622-8.
    View in: PubMed
    Score: 0.004
  64. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006 Jan 09; 166(1):106-11.
    View in: PubMed
    Score: 0.004
  65. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 2006 Jan 03; 113(1):20-9.
    View in: PubMed
    Score: 0.004
  66. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005 Nov; 54(11):3252-7.
    View in: PubMed
    Score: 0.004
  67. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005 Dec; 26 Suppl 1:11-6.
    View in: PubMed
    Score: 0.004
  68. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005 Dec 01; 80(1):45-53.
    View in: PubMed
    Score: 0.004
  69. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med. 2005 Sep-Oct; 67(5):692-6.
    View in: PubMed
    Score: 0.004
  70. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005 Dec 01; 80(1):19-32.
    View in: PubMed
    Score: 0.004
  71. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol. 2005 Oct 01; 162(7):644-53.
    View in: PubMed
    Score: 0.004
  72. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005 Mar 15; 142(6):393-402.
    View in: PubMed
    Score: 0.004
  73. Coronary heart disease risk in men and the epidemic of overweight and obesity. Int J Obes (Lond). 2005 Mar; 29(3):317-23.
    View in: PubMed
    Score: 0.004
  74. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005 Jan; 45(1):28-33.
    View in: PubMed
    Score: 0.004
  75. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004 Jul 27; 110(4):380-5.
    View in: PubMed
    Score: 0.004
  76. Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study. Am J Epidemiol. 2004 May 15; 159(10):950-8.
    View in: PubMed
    Score: 0.004
  77. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004 Mar; 27(3):704-8.
    View in: PubMed
    Score: 0.004
  78. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation. 2004 Mar 16; 109(10):1267-71.
    View in: PubMed
    Score: 0.004
  79. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J. 2004 Mar; 25(6):523-30.
    View in: PubMed
    Score: 0.004
  80. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004 Feb; 35(2):404-9.
    View in: PubMed
    Score: 0.003
  81. Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study. Hypertension. 2003 Dec; 42(6):1100-5.
    View in: PubMed
    Score: 0.003
  82. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003 Feb; 27(2):260-8.
    View in: PubMed
    Score: 0.003
  83. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002 Sep 09; 162(16):1867-72.
    View in: PubMed
    Score: 0.003
  84. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000 Jun 15-30; 19(11-12):1495-522.
    View in: PubMed
    Score: 0.003
  85. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med. 1997 Jan; 102(1):38-47.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.